annual cash & cash equivalents:
$41.67M-$44.43M(-51.61%)Summary
- As of today (September 17, 2025), EWTX annual cash & cash equivalents is $41.67 million, with the most recent change of -$44.43 million (-51.61%) on December 31, 2024.
- During the last 3 years, EWTX annual cash & cash equivalents has risen by +$26.10 million (+167.67%).
- EWTX annual cash & cash equivalents is now -60.29% below its all-time high of $104.92 million, reached on December 31, 2020.
Performance
EWTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$593.99M+$157.60M(+36.12%)Summary
- As of today (September 17, 2025), EWTX quarterly cash & cash equivalents is $593.99 million, with the most recent change of +$157.60 million (+36.12%) on June 30, 2025.
- Over the past year, EWTX quarterly cash & cash equivalents has increased by +$82.24 million (+16.07%).
- EWTX quarterly cash & cash equivalents is now at all-time high.
Performance
EWTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EWTX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.6% | +16.1% |
| 3 y3 years | +167.7% | +139.1% |
| 5 y5 years | +76.2% | - |
EWTX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.6% | +167.7% | at high | +139.1% |
| 5 y | 5-year | -60.3% | +167.7% | at high | +466.2% |
| alltime | all time | -60.3% | +167.7% | at high | +466.2% |
EWTX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $593.99M(+36.1%) |
| Mar 2025 | - | $436.39M(-7.2%) |
| Dec 2024 | $41.67M(-51.6%) | $470.17M(-4.5%) |
| Sep 2024 | - | $492.54M(-3.8%) |
| Jun 2024 | - | $511.75M(-3.9%) |
| Mar 2024 | - | $532.76M(+67.3%) |
| Dec 2023 | $86.10M(+291.5%) | $318.39M(+9.9%) |
| Sep 2023 | - | $289.70M(-6.5%) |
| Jun 2023 | - | $309.93M(-5.5%) |
| Mar 2023 | - | $327.95M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $21.99M(+41.3%) | $351.95M(-3.5%) |
| Sep 2022 | - | $364.82M(+46.9%) |
| Jun 2022 | - | $248.40M(-6.6%) |
| Mar 2022 | - | $265.83M(-5.3%) |
| Dec 2021 | $15.57M(-85.2%) | $280.79M(-3.3%) |
| Sep 2021 | - | $290.48M(-2.9%) |
| Jun 2021 | - | $299.15M(-3.5%) |
| Mar 2021 | - | $309.87M(+195.4%) |
| Dec 2020 | $104.92M(+343.6%) | $104.92M |
| Dec 2019 | $23.65M | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Edgewise Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of EWTX is $41.67M
What is the all time high annual cash & cash equivalents for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual cash & cash equivalents is $104.92M
What is Edgewise Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, EWTX annual cash & cash equivalents has changed by -$44.43M (-51.61%)
What is Edgewise Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EWTX is $593.99M
What is the all time high quarterly cash & cash equivalents for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $593.99M
What is Edgewise Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, EWTX quarterly cash & cash equivalents has changed by +$82.24M (+16.07%)